Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease

Prospective, Observational, Multi-center, Non-interventional Study to Assess Patients Perception in SYmptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00894426

Acronym

SYMBOL

Enrollment

150

Registered

2009-05-07

Start date

2009-05-31

Completion date

2009-12-31

Last updated

2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, Symptom, Morning activity, Questionnaire

Brief summary

The aim of this study is to assess the perception of chronic obstructive pulmonary disease (COPD) patients in symptoms related to morning activities. Also the researchers investigated how to describe the impact of symptoms on sleep quality and how to use the medication in Korea COPD treatments.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* COPD outpatients over 45 years old * Lung function: post-FEV1 \< 50% * Current or ex-smoker \> 10 packs per year * Patients who were not on medication of ISC/FC at least 2 weeks

Exclusion criteria

* Ongoing exacerbation of COPD or within the previous 3 months * History of asthma or allergic rhinitis * Lung cancer or any other significant respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease, tuberculosis, sarcoidosis * Current participation in an interventional clinical trial

Design outcomes

Primary

Measure	Time frame
To assess the perception of COPD Patients in symptoms related to morning activities	At baseline and last visit (after 2~3 months)

Secondary

Measure	Time frame
To describe how patients use their COPD treatments	At baseline and last visit (after 2~3 months)
To assess the patient's perception of the variability of symptoms	At baseline and last visit (after 2~3 months)
To investigate factors that may influence the patient's perception of symptom variability (such as patient characteristics, COPD treatments, co morbidities, etc…)	At baseline and last visit (after 2~3 months)

Countries

South Korea

Outcome results